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factor-secreting Lactococcus lactis promotes the
growth performance of early-weaned piglets
Dingyue Wang†, Shengyu Xu†, Yan Lin, Zhengfeng Fang, Lianqiang Che, Bai Xue and De Wu*Abstract
Background: Epidermal growth factor (EGF) is an important growth factor in regulation of cell proliferation,
differentiation, survival and apoptosis. Studies showed that food-grade Lactococcus lactis (L. lactis) and NICE
expression system have superior performance in exogenous protein expression. This study aimed to construct
and express porcine EGF (pEGF), and use L. lactis as vehicle for producing and delivering pEGF. Furthermore,
investigating biological activity of pEGF and exploring applications feasibility of combination effects of L. lactis and
pEGF on early weaned piglets’ production.
Results: A recombinant Lactococcus lactis which produced and secreted pEGF at 1000 ng/ml in culture supernatant
was generated. Secreted pEGF was a fully biologically active protein, as demonstrated by its capacity to stimulate
L929 mouse fibroblast cell line proliferation in vitro. For in vivo study, forty piglets were randomly allocated to
control, antibiotic control, empty vector-expressing L. lactis (LL-EV) and pEGF-secreting L. lactis (LL-pEGF). After 14 d
of rearing, final body weight and average daily gain in LL-pEGF were greater (P < 0.05, 8.95 vs. 8.37 kg, 206.1 vs.
157.7 g/day, respectively) than those in control, but no significant differences between LL-pEGF, LL-EV and antibiotic
control. Overall period average daily feed intake was higher in LL-pEGF, LL-EV and antibiotic control than in control
(P < 0.05, 252.9, 255.6, 250.0, 207.3 g/day, respectively). No significant difference was observed on ADFI/ADG.
LL-pEGF increased villous height in the duodenum, jejunum and ileum than in control and LL-EV (P < 0.05). Sucrase
in the 3 intestinal segments, aminopeptidase A in the duodenum and Jejunum, aminopeptidase N and dipeptidase
IV in the duodenum in LL-pEGF were higher than those in control (P < 0.05). Furthermore, Escherichia coli and
Enterococcus counts decreased in the ileum and Lactobacillus increased in the ileum and cecum digesta in LL-pEGF
compare with the control (P < 0.05). Lactobacillus increased in the cecum in LL-EV compared with control and
antibiotic control (P < 0.05).
Conclusion: We have generated a recombinant Lactococcus lactis which produced and secreted fully biologically
active porcine EGF. Oral administration of pEGF-secreting L. lactis had beneficial effects on intestinal health and
performance of early-weaned piglets.
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Free-ranging domestic piglets start to eat solid food from
the age of about 3 weeks, and gradually eat increasing
amounts of solid food before weaning at between 13 weeks
and 17 weeks when the piglet has free access to its mother,
closely resembling that of wild boars and feral pigs [1-4].
The weaning time is reported to be earlier in a loose-
housing system of about 11 weeks to 12 weeks [5]. Based
on information from several experiments and surveys, it
has been concluded that early weaning at 3-4 weeks can
be an effective management strategy to improve wean-to-
finish growth performance and provide a higher number
of piglets per sow per year in commercial multi-site pro-
duction systems which would well control the disease
transfer from the sow to the piglet [6]. When weaning at
this time, a piglet’s digestive apparatus is undeveloped and
an abrupt transition from maternal milk to solid feed en-
tails several problems. This leads to damaged mucosal
integrity and reduced enzyme activities, and quite an
amount of undigested nutrients are available for enteric
pathogenic bacteria, which changes the intestinal micro-
biota and increases the rate of diarrhea. Although the
application of antibiotics alleviated this problem to some
extent, antibiotic use induced antibiotic-resistant bacteria
generation, resulting in restriction of the use of antibiotics
in present animal production [7-9]. How to help piglets
overcoming post-weaning stress without any side effects
are attracting people's attention at the present stage.
Stimulatory effects of colostrums and milk on growth
and development of the intestine have long been recog-
nized, and the putative role of milkborne growth factors
in mediating this development has been the subject of
considerable investigation [10,11]. Epidermal growth fac-
tor (EGF), a small mitogenic polypeptide comprising 53
amino acid residues is typically present at about 1500 ng/
ml and 124 ng/ml in porcine colostrum and mature milk,
respectively [12]. EGF is synthesized in the salivary glands
and kidneys and, to a lesser extent, in the lactating mam-
mary glands, small intestine, liver and pancreas [13-15].
EGF has high stability in the gastrointestinal tract of hu-
man, mouse, rat and pig, especially in the gastric lumen
and the proximal and mid-intestine lumen, with a higher
degradation in the distal intestine lumen [16-20]. EGF sig-
nals via binding to the EGF receptor (EGFR, also known
as ErbB1), a transmembrane receptor tyrosine kinase of
the ErbB family [21,22]. Binding of EGF receptor to EGF
leads to autophosphorylation of receptor tyrosine kinase
and subsequent activation of signal transduction pathways
that are involved in regulating cellular survival, growth,
proliferation and differentiation [23,24]. The effects of
EGF in stimulating growth of the gastrointestinal tract
and inducing small intestinal enzymes have been reported
[12,25-27]. EGF was also found to reduce the colonization
of the intestinal epithelium by enteropathogens [28].Lactococcus lactis is a food-grade, Gram-positive lactic
acid bacterium that, in addition to its traditional use in
food fermentations, is increasingly used in modern bio-
technological applications. L. lactis is a novel cell factory
for the production of proteins and bioactive compounds.
Using pAMJ399 as an expression vector, which contains
a pH-regulated promoter, P170, and an erythromycin-
resistance gene for selection, Cheung et al. (2009) found
that the transgenic L. lactis produced about 0.5 ug EGF
per milliliter culture supernatant [29]. However, tran-
scription from P170 was induced between pH 6.5 and
pH 6.0, only when the culture entered stationary phase
[30]. The protein production ability of L. lactis was facili-
tated by the development of an efficient expression sys-
tem, such as the Nisin-controlled expression (NICE)
system. The NICE system consists of a bacterial host with
nisRK regulatory genes integrated into the chromosome
and an expression vector carrying the gene of interest
under the control of a nisA promoter [31]. Using this sys-
tem, expression can be efficiently controlled through the
addition of nisin [31]. The ups45 gene encodes the major
extracellular protein Usp45 from L. lactis MG1363. Chi-
meras of the 27-amino-acid Usp45 signal peptide (SPusp45),
fused to a number of mature proteins and peptides, have
been used to drive secretion by L. lactis, which is metabol-
ically active in all compartments of the intestinal tract.
Kuipers et al. (1995) found that lactococcal nisin biosyn-
thesis was autoregulated in L. lactis [32]. Further study
established that exogenous proteins production continued
in L. lactis 10 h after a 1-h nisin-pulse induction [33].
Therefore, NICE system is an ideal expression system to
secrete foreign proteins. The first objective of the present
study was to test the hypothesis that porcine EGF can be
produced and efficiently secreted in the NICE system by
L. lactis in a soluble and biologically active form. A second
objective was to further determine the effects of oral
administration pEGF-secreting L. lactis whole-cell sus-
pension on intestinal development, digestive enzyme ac-
tivities, intestinal microbiota and the performance of
segregated early weaned pigs, to explore the application
feasibility of the effects of microflora and specificity
functional protein in the actual production.
Methods
Bacterial strains, plasmids and growth media
The expression strain L. lactis NZ9000 (NIZO food re-
search B.V., Netherlands) was propagated in M17 (Difco,
NJ, USA) containing 0.5% (wt/vol) glucose at 30°C
without shaking. Escherichia coli (E. coli) DH5α strains
were grown in Luria-Bertani medium at 37°C under
aeration. The expression vector pNZ8148 (NIZO food
research B.V., Netherlands) used in L. lactis NZ9000
has a chloromycetin-resistance gene for selection. An-
tibiotics were used when appropriate at the following
Figure 1 Schematic representation of pNZ8148-SPUsp45-MpEGF
vector expression of MpEGF in L. lactis. A 159-bp DNA fragment
encoding mature porcine EGF (MpEGF) was fused in frame with an
81-bp DNA fragment containing the Usp45 signal peptide, derived
from the predominant L. lactis-secreted protein. In this plasmid,
pEGF expression is controlled by the nisin-inducible promoter
(PnisA). The pNZ8148-SPUsp45-MpEGF carries the chloramphenicol
resistance marker (cm).
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ml ampicillin.
Construction of recombinant L. lactis NZ9000/pNZ8148-
SPUsp45-MPpEGF
Total RNA was isolated form renal tissue of newborn
Meishan piglets using the Trizol (Invitrogen, Carlsbad,
CA, USA) method according to the manufacturer’s in-
structions. Reverse transcription and polymerase chain
reactions (PCR) were carried out to amplify the mature
pEGF (MPpEGF) sequence (GenBank: NM_214020.1,
2908..3066), using forward primers F1, F2, F3 and re-
verse primer R. The sequence of the primers were (Bold
letters indicate the addition of restriction enzyme sites
of NcoI and SacI): F1, 5′-GCT GCA GCC CCG TTG
TCA GGT GTT TAC GCT AAT AGT TAC TCT GAA
TGC C-3′; F2, 5′-CA GCT ATT TTA ATG TCT ACA
GTG ATA CTT TCT GCT GCA GCC CCG TTG TCA
G-3′; F3, 5′-CAT GCC ATG GCT AAA AAA AAG
ATT ATC TCA GCT ATT TTA ATG TCT AC-3′ and R:
5′-C GAG CTC TTA GCG CAG CTC CCA CCA TTT
CAA G-3′. The signal sequence of the major secreted pro-
tein Usp45 of L. lactis subsp. cremoris MG1363 was con-
tained in the forward primers F1, F2, and F3 with a whole
length of the 81 base pairs (GenBank EU382094.1). A
unique high fidelity DNA polymerase PrimeSTARTM HS
DNA Polymerase (TaKaRa, Osaka, Japan) was used in
PCR. The PCR conditions were [98°C (10 sec), 55°C
(5 sec), 72°C (1 min)] for 30 cycles. The primers amplified
a 259-bp fragment contained 81-bp of SPUsp45 and 159-
bp of MPpEGF. TaKaRa LA Taq (Takara, Osaka, Japan)
was finally used to amplify the 259-bp DNA fragment with
a 3′-A for TA cloning with forward primer F3 and reverse
primer R. The 259-bp fusion fragment was verified by
1.2% agarose gel electrophoresis and gel-purified by using
an E.Z.N.A.™ Gel Extraction Kit and ligated into pMD19-
T Simple Vector to generate pMD19-SPUsp45-MPpEGF.
After transforming into E. coli DH5α competent cells,
positive clones were identified by sequencing, and then
pMD19-SPUsp45-MPpEGF was digested with NcoI and
SacI to release the SPUsp45-MPpEGF insert. The puri-
fied insert was subsequently cloned into the corre-
sponding site of expression vector pNZ8148 that was
linearized with NcoI and SacI. The resultant construct,
known as pNZ8148-SPUsp45-MPpEGF, had a sequence
of SPUsp45-MPpEGF placed behind the inducible pro-
moter PnisA on the plasmid (Figure 1). The expression
construct was then transformed into E. coli MC1061;
DNA sequencing confirmed the identity of the plasmid.
Finally, the plasmid was transformed into L. lactis NZ9000
competent cell by electroporation. Recombinant L. lactis
NZ9000/pNZ8148-SPUsp45-MPpEGF was amplified with
primers F0 (F0: 5′-ATAACGCGAGCATAATAAAC-3′)
and R and sequenced to select positive recombinantstrains. The empty vector pNZ8148 was also trans-
formed into L. lactis NZ9000 and was designated as a
control (LL-EV).
Nisin induction
According to the growth and induction condition for L.
lactis optimized by NIZO, nisin induction of the recom-
binant L. lactis strain was performed as follows. From a
culture grown overnight, a 4% (vol/vol) inoculum was
transferred to fresh medium and bacteria were grown at
30°C until the optical density at 600 nm was 0.4. Nisin A
(Sigma, St Louis, MO, USA) was added at a final con-
centration of 1 ng/ml, and L. lactis cells were propagated
for 4 h to 24 h before harvesting.
Western blot analysis
Western blotting was performed as described [34]. Pro-
teins in cell lysates and supernatant fluids were separated
on 15% sodium dodecyl sulfate polyacrylamide gels
and then transferred to polyvinylidene fluoride (PVDF;
Millipore, Billerica, MA, USA) membranes. The blots
were blocked in skim milk-phosphate-buffered saline
(PBS) and then incubated with primary anti-EGF (1:500
dilution; Cell Sciences, Canton, MA), followed by incuba-
tion with a secondary antibody (anti-rabbit IgG horserad-
ish peroxidase-linked anti body, 1:2000; Cell Signaling
Technology, MA, USA). Proteins were detected by the
enhanced chemiluminescence (ECL) Advance Western






Dehulled soybean meal 135.00
Full fat extruded soybean 80.00
Fish meal 40.00
















Digestible energy (KJ/kg) 14460
Crude protein (%) 20.27
Crude fat (%) 3.70
Lysine (%) 1.33
Met + Cys (%) 0.75
Calcium (g/kg) 8.40
Phosphorous (g/kg) 6.30
aSupplied per kilogram diet: Vitamin A, 2, 800 IU; Vitamin D3 320 IU; Vitamin E,
20 IU; Vitamin K3, 1 mg; Vitamin B1, 1.5 mg; Vitamin B2, 5 mg; Vitamin B6,
2 mg; Vitamin B12, 0.03 mg; Nicotonic, 20 mg; Pantothenic, 15 mg; Folic acid,
0.5 mg; Biotin, 0.1 mg.
bSupplied per kilogram diet: Cu 6 mg, Fe 100 mg, Mn 4 mg, Zn 100 mg, I
0.14 mg, Se 0.3 mg, Cr 0.2 mg.
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Densitometric analyses of band intensities were performed
using GeneTools (Syngene, Frederick, MD, USA). Each
experiment was repeated at least three times.
In vitro cell proliferation assay
A L929 mouse fibroblast cell line (ATCC Cat. No. CCL-1)
was used in an in vitro cell proliferation assay. Cells were
seeded in a 6-well culture plate at an initial density of
0.16 × 105 cells/well with 2.5 ml Dulbecco′s Modified
Eagle′s Medium (DMEM) containing 100 IU/ml penicillin
sodium, 100 μg /ml streptomycin sulfate and 10% fetal bo-
vine serum (FBS). Cells were incubated at 37.0°C in 5%
carbon dioxide until 60% confluent. Culture medium was
removed and cells were washed 3 times with D-Hanks so-
lution. Subsequently, the cells were incubated in DMEM
for 24 h to achieve serum deprivation. Then cells were
washed twice with D-Hanks and fresh DMEN medium
without FBS and were used for further culture. Cells were
treated immediately with the following groups: recombin-
ant human EGF (rhEGF; Cell science; 20 ng/ml), super-
natant fluid collected from 24 h nisin A induced L. lactis
NZ9000/pNZ8148–SPUsp45-MPpEGF (LL-pEGF; 10 or
20 μl), and supernatant fluid collected from L. lactis
NZ9000/pNZ8148 cultured at the same time as the
control (LL-EV; 20 μl). All the supernatants from the
cultures were filtered by using 0.22-μm sterile syringe
filters before being added into the cell culture medium.
After 24 h treatment, cells were trypsinized and quanti-
fied using a hemocytometer. Cell counting was done in
a blinded-manner by a 3rd party that was not aware of
the experimental treatment.
Piglets and diet treatment
Forty-five crossbred piglets (Duroc × Landrace × Yorkshire)
weaned at 21 days were obtained from New Hope Group
(Chengdu, SC). After two days of transition feeding, 40 pig-
lets were selected and assigned to 1 of the 4 treatment
groups based on sex and body weight: control (M17 broth),
antibiotic control (kitasamycin, 25 mg/kg diet), LL-EV
(empty vector control, no pEGF was detected) and LL-
pEGF (1.8 ug/ml pEGF, the concentration calculated based
on the supernatant fluids and the L. lactis cell lysates), and
each treatment had 10 replicates (5 males and 5 females).
All the piglets were fed separately in a metabolic cage with
a nipple waterer and a stainless steel feeder for a 14 d ex-
perimental period. The piglets were provided ad libitum
access to water and diet. The basal diet represented a typ-
ical commercial corn-soybean meal that met the nutrient
requirements suggested by the National Research Council
(1998). The diets (Table 1) did not contain any feed antibi-
otics except for the diet used for piglets in antibiotic con-
trol group. Piglets were reared in an environmentally
regulated nursery house in Sichuan Agricultural University.Food intake of each piglet was recorded every day and
bodyweight was recorded every 7 d. The study was con-
ducted according to the guidelines from the Chinese
Council of Animal Care and was approved by the
Sichuan Agricultural University Animal Care Commit-
tee and all in vivo experiments in accordance with the
ARRIVE guidelines.
LL-pEGF was induced for 24 h as described above,
and at the same time LL-EV was harvested and used for
the treatments of LL-pEGF and LL-EV. Bacterial cultures
were delivered to piglets as a whole-cell suspension. All
the piglets were orally fed 50-ml doses, via intragastric
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at 08:00 and 15:00. The piglets in the treatment of con-
trol were orally administrated 50-ml sterile M17 broth,
and the piglets in the antibiotic control treatment were
fed with 50-ml physiological saline in the same manner
to create the same stress produced by gavage with
other treatments.
Intestinal sample collection
At the end of the experiment, randomly selected six pig-
lets (3 males and 3 females) from each treatment were
anaesthetized with an intravenous injection of sodium
pentobarbital [25 mg/kg body weight (BW)] and bled by
exsanguinations. The piglet abdomen was opened imme-
diately from the sternum to the pubis; the entire intestine
was rapidly removed. A 15 cm section of distal duodenum,
mid-jejunum and mid-ileum were ligated and removed to
avoid chyme admixture in different intestinal sections.
The small intestine was placed on a chilled stainless steel
tray. A small incision was opened in the distal end of each
segment, and the chyme was collected in a 5 ml tube and
stored at 4°C. Two segments of 2 cm and 10 cm were cut
at the distal duodenum, mid-jejunum and mid-ileum. The
2 cm intestinal segments were flushed gently with ice-cold
PBS (pH 7.4) and then placed in 10% fresh, chilled forma-
lin solution for histological measurement. Intestinal seg-
ments (10 cm in length) were opened longitudinally and
the contents were flushed with ice-cold PBS. Mucosa was
collected with scraping on a sterile glass microscope slide,
which was placed on an ice-cold tray, rapidly frozen in
liquid nitrogen and stored at -80°C until analysis. Intes-
tinal sections used for histological measurement or mu-
cosa collection were sampled at the same location of
each piglet. All samples were collected within 20 min
after being killed.
Intestinal morphology
Formalin-fixed duodenum, jejunum and ileum samples
were embedded in paraffin. Cross sections of the segments
were cut with a microtome to be approximately 5-μm
thick and were stained with hematoxylin and eosin. At
least 4 sections of each of the small intestinal segments
were checked, and more than 6 complete villous-crypt
structures were examined under a microscope in each
section. The villus height and the associated crypt depth
were measured using a microscope with a Leica Q500MC
computer-assisted morphometric system. Villus height
was defined as the distance from the villus tip to the crypt
mouth, and crypt depth from the crypt mouth to the base.
Brush border enzyme activity
The enzymes studied were lactase (EC 3.2.1.23), sucrase
(EC 3.2.1.48), maltase (EC 3.2.1.20), aminopeptidase A (EC
3.4.11.1), aminopeptidase N (EC 3.4.11.2) and dipeptidylpeptidase IV (EC 3.4.14.5). All assays were carried out on
homogenates of mucosal tissue obtained by thawing ap-
proximately 1 g of tissue and homogenizing it in 9 ml PBS
(pH= 7.2) using an ultrasonic homogenizer. The sample
was stored at -80°C before being assayed. Lactase, sucrase
and maltase activities were assayed as described by
Petersen et al. [35]. The protein content in mucosal ho-
mogenates was measured according to Lowry et al. [36],
using bovine serum albumin (A 7638, Sigma Chemical,
St. Louis) as the standard.
A porcine aminopeptidase A (APA) ELISA Kit (R&D
Systems Inc., MN, USA), porcine aminopeptidase N (APN)
ELISA Kit (R&D Systems Inc., MN, USA) and porcine di-
peptidase IV (DPP-IV) ELISA Kit (R&D Systems Inc., MN,
USA) were used for quantitative detection of APA, APN
and DPP-IV. Enzymes were first combined to the solid-
phase antibody, and then the combined antibody, which
was labeled with horseradish peroxidase (HRP) to form an
antibody-antigen-enzyme-antibody complex. 3,3′,5,5′-Tet-
ramethylbenzidine (TMB), was used as substrate to be
enzyme-catalyzed by HRP. The reaction was terminated by
addition of a sulphuric acid solution and measured spec-
trophotometrically at a wavelength of 450 nm. The enzyme
activities were expressed as units per milligram or nano-
gram per gram of mucosa.
Intestinal microbiota assay
The microbiological assay of ileum and cecum digesta was
carried out according to the procedure of Torrallardona
et al. [37]. The digesta collected from the ileum and cecum
was homogenized in a sterile salt solution (NaCl 0.85%).
Bacterial quantifications for homogenized liquid were
made using serial 10 fold dilutions in the sterile salt solu-
tion (NaCl 0.85%), followed by plating on an agar medium.
The samples of ileal and cecal digesta were cultured in dif-
ferent media for the determination of E. coli (MacConkey
agar; Merck, Darmstadt, Germany), Enterococcus (EC agar;
Merck, Darmstadt, Germany), Bifidobacterium (BL agar;
Difco, NJ, USA) and Lactobacillus (MRS agar; Oxoid,
Hampshire, UK). The concentration of bacteria in the
original sample was calculated as the mean of three di-
lutions for each sample. The results are expressed as the
mean of log10 colony forming units (cfu)/g digesta from
the 6 piglets with the standard deviations.
Statistical analyses
Western blot and in vitro cell proliferation assays were
repeated at least three times, with data representing the
mean values with standard deviations of all repeats within
an individual experiment. For the animal trial, the experi-
mental model used was a completely randomised design
with four treatments and the individual piglets were the ex-
perimental units, with data representing the mean values
with their standard deviations of all experimental units.
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(ANOVA) followed by either the Bonferroni test for se-
lected pair comparisons [Table 2, final weight, average
daily gain (ADG) of second week, average daily feed in-
take (ADFI) of first week and overall period; Figure 2A
(II), the Enterococcus quantification; Figure 2B [I], the E.
coli quantification], or the Tukey test for multiple com-
parisons (all other tables and figures) for ANOVA to de-
termine statistical differences between groups using
GraphPad Prism analysis software. Results were consid-
ered significant at P < 0.05.
Results
Characterization of pEGF production by L. lactis
The secreted porcine EGF bands of 6.0 kDa were de-
tected in nisin-induced cultures of the LL-pEGF strain,
and no signal was detected in non-induced LL-pEGF
cultures by western blotting (Figure 3A). The concentra-
tion of porcine EGF in the recombinant bacterial culture
supernatant collected after 24 hours of incubation was
1000 ng/ml based on comparative densitometry analysis
of the bands with that of a known amount of rhEGF
(Figure 3B). Treatment of fibroblasts with supernatant
(10 μl or 20 μl) from the LL-pEGF culture significantly
(P = 0.003) increased cell numbers during a 24-h culture
compared with the control group in which 20 μl of the
supernatant from the LL-EV culture was added (Figure 4).
Recombinant pEGF secreted by L. lactis had the same bio-
logical activity as rhEGF for stimulating cell proliferation
(Figure 4).Table 2 Effects of diets supplemented with different additive
(Mean values and standard deviations)
Control Antibioti
Initial weight (kg) 6.16 ± 0.38 6.27 ± 0.1
Final weight (kg) 8.37 ± 0.43a 8.91 ± 0.3
ADG (g/day)
0-7 d 135.7 ± 21.8a 142.9 ± 31
8-14 d 179.6 ± 27.4a 230.3 ± 42
0-14 d 157.7 ± 25.4a 188.6 ± 31
ADFI (g/day)
0-7 d 168.1 ± 31.7a 191.1 ± 44
8-14 d 246.6 ± 31.1 300.8 ± 38
0-14 d 207.3 ± 27.0a 250.0 ± 37
ADFI/ADG
0-7 d 1.24 ± 0.12 1.39 ± 0.1
8-14 d 1.41 ± 0.32 1.31 ± 0.2
0-14 d 1.34 ± 0.25 1.34 ± 0.1
N = 10.
LL-EV, empty vector-expressing Lactococcus lactis group; LL-pEGF, pEGF-secreting La
feed intake.
a,bMeans with different superscripts in the same row indicate significant differencesGrowth performance of early-weaned piglets
The effects of dietary treatments on growth performance
of early-weaned piglets were illustrated in Table 2. LL-
pEGF group had higher final BW compare with the
control group (P = 0.044). Overall ADG (from 0 to 14 d,
P = 0.031), ADG of the first week (P = 0.019) and second
week (P = 0.043) in LL-pEGF group were greater than in
the control group. No significant differences were observed
in final BW and ADG among LL-pEGF, antibiotic control
and LL-EV groups. ADFI of first week was higher in LL-
pEGF and LL-EV than in the control group (P = 0.042).
The overall period ADFI were higher in LL-pEGF, LL-EV
and antibiotic control than in control group (P = 0.036).
No differences were observed on feed efficiency (expressed
as ADFI/ADG).
Intestinal development and brush border enzyme activity
As shown in Table 3, the length of villi in the duodenum
(P = 0.001), jejunum (P < 0.001) and ileum (P < 0.001) was
longer in the LL-pEGF treatment group than in control
and LL-EV groups. Antibiotic treatment showed higher
villi heights in the ileum than in controls (P < 0.001). In
terms of crypt depth, there was no significant difference
among the treatment groups at the duodenum, jejunum
and ileum.
Brush border enzyme activities are shown in Table 4.
No difference was observed in brush border lactase ac-
tivity in the duodenum, jejunum and ileum among the
treatments. Duodenum and jejunum sucrase activities in
LL-pEGF group were the same as that in antibiotics on growth performance of early-weaned pigs
c control LL-EV LL-pEGF
3 6.09 ± 0.19 6.06 ± 0.31
7ab 8.68 ± 0.36ab 8.95 ± 0.42b
.9ab 172.5 ± 30.4ab 178.6 ± 26.7b
.4ab 203.6 ± 33.3ab 233.7 ± 44.9b
.1ab 184.3 ± 29.5ab 206.1 ± 27.1b
.3ab 215.9 ± 28.4b 217.1 ± 40.1b
.0 295.5 ± 52.9 288.6 ± 34.9
.1b 255.6 ± 33.3b 252.9 ± 34.2b
1 1.31 ± 0.30 1.22 ± 0.15
0 1.45 ± 0.04 1.26 ± 0.21
4 1.39 ± 0.15 1.23 ± 0.12
ctococcus lactis group; ADG, Average daily gain; ADFI, Average daily
(P < 0.05).
Figure 2 Effects of different treatments on the ileum microbiota (A) and the cecum microbiota (B) of early-weaned piglets. A(I), E. coli
quantification in the ileum; A(II), Enterococcus quantification in the ileum; A(III), Lactobacillus quantification in the ileum. B(I), E. coli quantification
in the cecum; B(II), Lactobacillus quantification in the cecum. Results are expressed as the mean of log10 colony forming units (cfu)/g digesta with
standard deviations. Different lowercase letters denote statistical differences between groups (P < 0.05). Con., control; Antibotic, antibotic control;
LL-EV, empty vector-expressing Lactococcus lactis; LL-pEGF, pEGF-secreting Lactococcus lactis.
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that in controls group (P < 0.05). Ileum sucrase activity
in LL-pEGF group was greater (P = 0.018) than that in
antibiotic control group, control group and LL-EV group.
No differences were observed of maltase activity in the
duodenum and the jejunum among treatment groups, but
that in the ileum was greater (P < 0.05) in LL-pEGF group
than in antibiotic control group and LL-EV group. The ac-
tivity of APA, APN and DPP-IV were increased in the duo-
denum compared with controls and the antibiotic controls
(P < 0.05). The activity of APA also was increased in theLL-pEGF treatment group compared with the controls and
LL-EV treatment group in the jejunum (P < 0.05). There
were no significant differences among treatments in the ac-
tivities of APA in the ileum and APN and DPP-IV in the
jejunum and ileum (Table 4).
Intestinal microbiota
The number of E. coli in the ileum in LL-pEGF group
was similar (P > 0.05) to that in antibiotic control group,
lower (P = 0.01) than that in control group (Figure 2A
[I]). LL-pEGF and antibiotic treatments reduced the
2 h           4 h           8 h            12 h           16 h          24 h
4 h      12 h      24 h
Supernatant (40 µl)rhEGF
NI
Supernatant (20 µl)rhEGF (ng)
10 ng
10       20       30
A
B
Figure 3 Quantification of porcine EGF secreted by L. lactis. A) Western blot analysis shows that the 6.0-kD porcine EGF was present in the
supernatant of the induced LL-pEGF fermentation cultures, and no secreted pEGF was detected in the supernatant of the non-induced LL-pEGF
fermentation cultures (NI). B) A representative western blot of supernatants from the induced LL-pEGF. Supernatants of the LL-pEGF induced
at different times were used to determine the amounts of pEGF present in the culture supernatant by densitometry from three experiments.
The pEGF concentrations in the LL-pEGF culture were about 600 ng/ml, 900 ng/ml and 1000 ng/ml at 4 h, 12 h, and 24 h, respectively. rhEGF,
recombinant porcine epidermal growth factor; NI, non-induced LL-pEGF fermentation cultures.
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the ileum. There was no significant difference observed
in Bifidobacterium among the treatments (data not
shown) in the ileum. Oral administration of L. lactis-se-
creting pEGF resulted in an increase of 1.09 log10 cfu/gFigure 4 In vitro biological activity of porcine EGF produced by
L. lactis. Twenty-four hours after serum deprivation, L929 mouse
fibroblast cells were cultured for an additional 24 h in 2.0 ml of
DMEM containing 20 ng/ml of rhEGF, 20 μl of supernatant from
LL-EV, and 10 μl or 20 μl of supernatant from LL-pEGF. Results are
expressed as the cell numbers of each treatment and represent the
means of three independent experiments performed in triplicate.
Different lowercase letters denote statistical differences between
groups at P < 0.05. rhEGF, recombinant porcine epidermal growth
factor; LL-EV, empty vector-expressing Lactococcus lactis; LL-pEGF,
pEGF-secreting Lactococcus lactis.and 1.31 log10 cfu/g in the number of Lactobacillus in
the ileal digesta compared with controls and antibiotic
treatments, respectively (P < 0.05, Figure 2A [III]).
For the microbiota in the cecum, compared with the
control and LL-VE treatments, antibiotic treatment and
LL-pEGF decreased the number of E. coli (P = 0.004,
Figure 2B [I]). No significant difference was observed in
Enterococcus and Bifidobacterium among the treatments
(data not shown) in the cecum. Oral administration of
L. lactis-secreting pEGF increased the amount of Lactoba-
cillus in the cecum by 0.82 log10 cfu/g and 1.19 log10 cfu/g
compared with the control and antibiotic treatments,
respectively (P < 0.001, Figure 2B [II]). LL-VE treatment
also increased the amount of Lactobacillus in the cecum
compared with the control and antibiotic treatments,
respectively (P < 0.001, Figure 2B [II]).
Discussion
Early weaning has been used extensively to shorten inter-
val of farrowing thus improve litter size per year and con-
trol the transfer of disease from the sow to the piglet, but
the weaning stress was consequently intensified in piglets,
which induced an intestinal villi height decrease and crypt
depth increase, and enhanced the rate of diarrhea [38-40].
The problem of piglets overcoming post-weaning stress
has plagued people for a long time. The application of an-
tibiotics do played an important role at this problem, but
it also has the limitations due to the antibiotics resistance
[7,8]. The current study demonstrated that supplementing
Table 4 Effects of diets supplemented with different additives on brush border enzyme activity of early-weaned piglets
(Mean values and standard deviations)
Control Antibiotic control LL-EV LL-pEGF
Lactase (U/mg)
Duodenum 2.73 ± 0.75 2.07 ± 0.98 1.90 ± 0.29 2.63 ± 0.63
Jejunum 1.32 ± 0.27 1.37 ± 0.48 1.56 ± 0.53 1.24 ± 0.33
Ileum 0.43 ± 0.19 0.45 ± 0.22 0.36 ± 0.09 0.40 ± 0.11
Sucrase (U/mg)
Duodenum 0.69 ± 0.43a 0.99 ± 0.46ab 1.92 ± 1.35ab 2.84 ± 1.00b
Jejunum 3.12 ± 2.28a 5.83 ± 2.58ab 7.03 ± 0.87ab 9.49 ± 2.28b
Ileum 8.91 ± 0.42a 9.08 ± 1.51a 9.13 ± 0.95a 11.33 ± 0.93b
Maltase (U/mg)
Duodenum 9.19 ± 1.35 7.17 ± 1.76 10.26 ± 2.45 12.07 ± 3.91
Jejunum 3.78 ± 1.89 4.09 ± 1.61 2.43 ± 0.78 4.74 ± 1.77
Ileum 6.93 ± 1.10ab 4.21 ± 1.42a 4.77 ± 1.45a 10.18 ± 3.30b
APA (ng/g)
Duodenum 23.21 ± 2.16a 20.89 ± 2.64a 25.96 ± 4.33ab 35.19 ± 7.52b
Jejunum 23.24 ± 1.30a 29.68 ± 1.31ab 23.39 ± 5.38a 35.20 ± 4.35b
Ileum 33.69 ± 7.22 33.74 ± 2.07 32.23 ± 3.82 33.20 ± 5.83
APN (ng/g)
Duodenum 8.33 ± 1.44a 6.96 ± 0.68a 9.98 ± 1.27ab 12.33 ± 2.70b
Jejunum 9.27 ± 1.81 9.61 ± 2.83 10.42 ± 1.46 12.44 ± 2.25
Ileum 11.23 ± 2.53 12.15 ± 1.62 11.61 ± 2.01 14.84 ± 3.68
DPP-IV (ng/g)
Duodenum 8.37 ± 1.11a 6.99 ± 0.87a 9.22 ± 1.39ab 11.89 ± 2.47b
Jejunum 10.03 ± 1.92 9.73 ± 0.86 8.34 ± 2.27 9.15 ± 2.44
Ileum 10.32 ± 1.97 10.65 ± 0.91 10.44 ± 1.28 13.35 ± 1.78
N = 6.
LL-EV, empty vector-expressing Lactococcus lactis group; LL-pEGF, pEGF-secreting Lactococcus lactis group; APA, aminopeptidase A; APN, aminopeptidase N;
DPP-IV, dipeptidase IV.
a,bMeans with different superscripts in the same row indicate significant differences (P < 0.05).
Table 3 Effects of diets supplemented with different additives on intestinal development of early-weaned pigs
(Mean values and standard deviations)
Control Antibiotic control LL-EV LL-pEGF
Villus height (μm)
Duodenum 275.59 ± 39.77a 299.25 ± 27.03ab 292.62 ± 19.30a 332.20 ± 40.82b
Jejunum 272.34 ± 39.69a 312.55 ± 47.44ab 282.95 ± 30.49a 345.07 ± 29.75b
Ileum 216.90 ± 25.54a 271.93 ± 39.91bc 235.29 ± 30.10ab 279.38 ± 41.66c
Crypt depth (μm)
Duodenum 230.71 ± 35.98 203.29 ± 19.75 209.89 ± 24.81 205.78 ± 30.47
Jejunum 202.51 ± 31.19 189.19 ± 22.81 191.98 ± 26.32 181.51 ± 28.46
Ileum 159.64 ± 24.57 143.58 ± 23.97 148.37 ± 28.10 143.70 ± 22.71
N = 6.
LL-EV, empty vector-expressing Lactococcus lactis group; LL-pEGF, pEGF-secreting Lactococcus lactis group.
a,b,cMeans with different superscripts in the same row indicate significant differences (P < 0.05).
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factor and the probiotics) facilitates intestinal health in
early-weaned piglets, which might be a new way to help
the animals overcome the weaning transition.
In this work, we cloned the porcine egf gene into a
nisin-controlled expression vector, resulting in a vector
that allows rapid and efficient secretion of soluble pEGF
by L. lactis. Western blot analyses showed that the con-
centrations of pEGF proteins were increased in the super-
natant of the induced LL-pEGF fermentation cultures that
were collected at different time points. The peak occurred
at 24 h after nisin was induced (no significant differences
in concentrations of pEGF proteins collected at 36 h and
48 h compared with 24 h, data not shown). The concen-
tration of pEGF from our nisin-controlled expression vec-
tor was higher than that from the pAMJ399 expression
vector (1000 ng/ml vs. 500 ng/ml) [29]. We demonstrated
that our recombinant pEGF is directly secreted in a bio-
logically active form, as shown by its capacity to efficiently
stimulate L929 mouse fibroblast cell proliferation. pEGF
production in a secreted form allows for direct assessment
of its biological activity in small volumes of culture
medium, without any purification steps. This procedure
was easily adapted for large-scale production of biologi-
cally active recombinant pEGF.
The role of EGF in stimulating intestinal epithelium
proliferation, differentiation and intestinal maturation has
been demonstrated [27,41,42]. EGF implements its func-
tion through binding to EGFR. Chandra and his colleagues
demonstrated that activation of EGFR increases the cell
number by promoting cell proliferation and suppressing
either serum depletion-induced or TNFα-induced apop-
tosis [43]. EGFR was found located on the basolateral sur-
faces in the infant and adult gastrointestinal tract [21,44].
In weaned pigs, EGFR appeared on both microvillar and
basolateral surfaces of enterocytes. In the duodenum,
EGFR was evenly distributed in the villi and crypts and
present to a lesser extent in the duodenal glands. In the je-
junum, most EGFR was seen in the top of the villi. In the
ileum, most EGFR was seen to decrease from the villus tip
to the crypt [45-47]. Furthermore, it has been suggested
that there are 10 times more EGF receptors than EGF
itself, which suggests that exogenous EGF administra-
tion may be taken up and well used by animals [48].
Consistent with previous reports, this study demon-
strated that our recombinant pEGF stimulates L929
mouse fibroblast cell proliferation in vitro and increases
mean villus height in vivo.
In the in vivo study, LL-pEGF improved final BW and
ADG compare with the control group, but its effects
were similar with the antibiotic control and LL-EV group.
The overall period ADFI were higher in LL-pEGF, LL-EV
and antibiotic control groups than in the control group.
The higher BW gain in LL-pEGF pigs could be resultingfrom the adequate intake of nutrients, as indicated by
the markedly increased ADFI in LL-pEGF pigs than in
control pigs. However, antibiotic and LL-EV supplementa-
tion were able to exert a growth rate similar to LL-pEGF
when receiving a similar feed intake.
The Oral administration of LL-pEGF to early-weaned
piglets enhanced intestinal development by increased villi
height in the three intestinal segments compared with
control and LL-EV group in this study. This is consistent
with previous reports regarding the possible promotion of
proliferation of EGF [26,27,49-51]. The antibiotics were
helpful to increasing the villi height compared with the
negative control in piglets [52-54]. In the present study,
villi height of the antibiotic group was increased compared
with control and were similar to LL-pEGF in the ileum.
The increased villous height implied the increased
surface area for nutrient absorption [55], thus may have
resulted in higher growth rate in the LL-pEGF treat-
ment than others.
Diets supplemented with the recombinant EGF from
Pichia pastoris strain elevated jejunal alkaline phosphat-
ase, sucrase, lactase and maltase activities in early-weaned
piglets [56]. In newborn and weaned piglets, systemic or
oral administration of EGF significantly increased jejunal
lactase and sucrase activities [12,25], suggesting EGF mod-
ulates enterocyte differentiation. It also reported that EGF
plays an important role in cell differentiation rather than
cell proliferation in young animals, and it may be involved
in stimulating mucus secretion [46]. Our findings that LL-
pEGF increases mean sucrase activities in the 3 intestinal
segments compared with control, maltase activities in the
ileum compared with antibiotic control and LL-EV group,
APA, APN and DPP-IV in the duodenum compared with
control and antibiotic control are consistent with these
reports. The elevation of intestinal enzyme activity in
LL-pEGF should be one reason to result in improvement
of growth performance in this study.
In addition, the intestinal microbiotas interact with host
intestinal epithelial cells and protect them from pathogens
via interference with pathogen adhesion and invasion [57].
They also affect the host through the immune response
and the metabolic products of fermentation processes.
Thus, the intestinal microbiota is very important for the
maintenance and recovery of intestinal health. An
impaired balance of the intestinal microbiota could have
many adverse effects on the health of the host [58]. Lacto-
bacillus has been shown to play a role in the inhibition of
pathogens in the intestine [59]. Here, we found that both
LL-pEGF and LL-EV treatments increased the amount of
Lactobacillus which suggests that part of the beneficial
effects of LL-pEGF can be attributed to the probiotic
properties of L. lactis. Although EGF did not affect the
proliferation of E. coli in vitro, it is reported that orally ad-
ministered EGF protects the gastrointestinal tract against
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Consistent with previous studies, we found LL-pEGF and
antibiotic control treatments decreased the amount of E.
coli in the ileum and cecum, and Enterococcus counts in
the ileum. It’s well known that the antibiotics would
inhibit harmful bacteria, but also the probiotics, and it’s
well demonstrated in the present study that the antibiotic
control decreased the amount of E. coli, Enterococcus and
Lactobacillus which would not conducive to the balance
of intestinal microbiota even affect the growth perfor-
mance of the pig in the subsequent growth stage. How-
ever, LL-pEGF ameliorated the intestinal microbial flora
by increasing the counts of probiotics L. lactis and inhi-
bited potential harmful bacteria E. coli and Enterococcus,
thus promoted intestinal health.
Conclusions
In summary, we have successfully designed a L. lactis strain
for highly efficient secretion pEGF, which can be directly
recovered from the culture medium. The in vitro study
showed that the secreted pEGF was a fully biologically
active protein. The results obtained from the in vivo study
indicated that oral administration of recombinant pEGF-
secreting L. lactis promotes the health of the intestine and
growth rate in early-weaned piglets. The potential bene-
fits of pEGF-secreting L. lactis in weaning transition
stage should make it acceptable as an alternative therapy
for farm animals during specific stages of development.
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